Therapeutic Classification

snri Registry

Clinical reference for snri medications. Access safety monographs, dosing adjustments, and drug-drug interactions for all registered brand names and generics in this class.

Registered Medications (snri)

Medication	Therapeutic Class	Maternal Safety
DESVENLAFAXINE MAOIs can cause serotonin syndrome Can increase blood pressure and cause withdrawal symptoms upon discontinuation.	SNRI	caution
DESVENLAFAXINE SUCCINATE MAOIs can cause serotonin syndrome Can increase blood pressure and cause withdrawal symptoms upon discontinuation.	SNRI	caution
DULOXETINE HYDROCHLORIDE MAOIs can cause serotonin syndrome Can cause hepatotoxicity and increase suicidal thoughts and behaviors.	SNRI	caution
Venlafaxine SNRI used for depression, anxiety, and panic disorder. Large cohort data are largely reassuring for MCM but some studies suggest a small increase in risk of cardiovascular defects and postpartum hemorrhage. More prominent neonatal withdrawal syndrome than SSRIs due to norepinephrine reuptake inhibition — neonatal adaptation syndrome may be more severe and longer lasting. Pulmonary hypertension of the newborn (PPHN) risk similar to SSRIs (small absolute risk).	SNRI	caution
VENLAFAXINE BESYLATE MAOIs can cause serotonin syndrome Can increase blood pressure and cause withdrawal symptoms upon discontinuation.	SNRI	caution
VENLAFAXINE HYDROCHLORIDE MAOIs can cause serotonin syndrome Can increase blood pressure and cause withdrawal symptoms upon discontinuation.	SNRI	caution

This therapeutic registry is dynamically synthesized from professional clinical sources. Listing of a medication does not imply equivalence; refer to individual monographs for head-to-head pharmacological data.